2024 innovations

Activities

Services

I can help

Documentation

icanhelp

GALLARDO Franck

Président directeur général
1 place Pierre Potier Oncopole Entrée B 31106 TOULOUSE
+0651441789

Documentation

Technical document

Disinfection systems validation

NeoVirTech

Hall 5a - K396 K396.
France
Our ANCHOR™ viruses are available for high-throughput imaging and screening, making them an accelerating tool for the development of disinfection systems (chemical, physical or radiative). Indeed, combined with high-throughput microscopy and detection algorithm, they offer the possibility of testing a large number of conditions with short turn-around times.
Our R&D platform will then support you in the calibration stages to ensure that this step is fast and efficient, from R&D to validation of final product.
Our ANCHOR™ viruses are available for high-throughput imaging and screening, making them an accelerating tool for the development of disinfection systems (chemical, physical or radiative). Indeed, combined with high-throughput microscopy and detection algorithm, they offer the possibility of testing a large number of conditions with short turn-around times.
Our R&D platform will then support you in the calibration stages to ensure that this step is fast and efficient, from R&D to validation of final product.

Innovation character

Our ANCHOR™ viruses enable real-time visualization of viral replication directly in living cells. Our viruses produce their own fluorescence which makes analysis and development time much shorter than traditional methods. We detect only infectious particles, speeding up the development of disinfection systems.

Potential for evolution

We can adapt our technology to all DNA viruses, enabling us to cover a wide range of viruses of military, civilian or veterinary interest. Some of our viruses are currently used in French army laboratories, and we have just been awarded the UAF label (Used by French Armed Forces). We can test any surface (from inert surface to BSL4 suits), water or air.

TRL10 - Commercialized